Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

Bone substitutes with NIPSA for intrabony periodontal defects

Official title: Regenerative Therapy of Intrabony Periodontal Defects Using Bone Substitutes and a Minimally Invasive Nonincised Papilla Surgical Approach - A Randomized Controlled Clinical Trial

Run by University of Belgrade · NCT07671963 · Data updated 2026-11-12

This study tests two bone substitutes (GTO and GenOs) used with the NIPSA technique to see which supports better gum and bone healing in adults with Stage III periodontitis.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Belgrade
Academic / other
Locations2 sites (Cagliari, Italy and 1 other locations)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedFebruary 1, 2027
Study endsMarch 1, 2027
Registry record updatedJune 26, 2026
Trial IDNCT07671963 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with Stage III periodontitis and at least one intrabony defect (>5 mm probing depth) after non-surgical therapy, and good oral hygiene.

Probably not a fit

Patients with uncontrolled systemic disease, poor oral hygiene, pregnancy, heavy smoking, radiotherapy history, or other exclusion criteria may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares two collagenated xenogeneic bone substitutes, GTO and GenOs, both used with the Non-Incised Papilla Surgical Approach (NIPSA) for treating intrabony periodontal defects. Outcomes include clinical attachment gain, radiographic defect fill, wound healing, and biomarkers of regeneration. Participants are adults with Stage III periodontitis and at least one suitable intrabony defect after nonsurgical therapy. The study aims to determine if material composition and form influence regenerative results and tissue stability. Safety and feasibility are monitored across multiple centers.

Why it matters

Potential benefit: If successful, the trial could identify which biomaterial plus NIPSA offers better regeneration and healing for intrabony defects.

How similar studies have gone: Prior work suggests biomaterial choice can affect regenerative outcomes, but direct head‑to‑head comparisons with NIPSA are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of Stage III periodontitis
* At least one intrabony periodontal defect with probing depth \> 5 mm following completion of non-surgical periodontal therapy
* Full-mouth plaque score (FMPS) \< 20%
* Full-mouth bleeding score (FMBS) \< 20%
* Ability to understand the study procedures and provide written informed consent

Exclusion Criteria:

* Systemic medical contraindications to periodontal surgery
* History of head and neck radiotherapy
* Poor oral hygiene or lack of motivation/compliance
* Uncontrolled diabetes mellitus
* Pregnancy or lactation
* Treatment with antiresorptive medications or other drugs affecting bone remodeling
* Heavy smoking (\>20 cigarettes/day)

Where it's running

  • Department of Periodontology, School of Dental Medicine, University of Cagliari Cittadella Universitaria di Monserrato Monserrato (CA), Italy
    Cagliari, Italy, Italy
    Recruiting
  • Department of Periodontology and Research Implant Center, School of Dental Medicine, University of Belgrade
    Belgrade, Serbia
    Recruiting

Study contacts

  • Principal investigator: Iva Z Milinkovic, DDS, PhD — School of Dental Medicine, University of Belgrade, Implant Research Centre and Department of Periodontology and Oral Medicine
  • Study coordinator: Iva Z Milinkovic, DDS, PhD
  • Email: iva.milinkovic@gmail.com
  • Phone: +381113629201

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.